Nuclear Hsp104 safeguards the dormant translation machinery during quiescence

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 5,17 MB, PDF-dokument

  • Verena Kohler
  • Andreas Kohler
  • Lisa Larsson Berglund
  • Xinxin Hao
  • Sarah Gersing
  • Axel Imhof
  • Thomas Nyström
  • Johanna L. Höög
  • Martin Ott
  • Claes Andréasson
  • Sabrina Büttner
The resilience of cellular proteostasis declines with age, which drives protein aggregation and compromises viability. The nucleus has emerged as a key quality control compartment that handles misfolded proteins produced by the cytosolic protein biosynthesis system. Here, we find that age-associated metabolic cues target the yeast protein disaggregase Hsp104 to the nucleus to maintain a functional nuclear proteome during quiescence. The switch to respiratory metabolism and the accompanying decrease in translation rates direct cytosolic Hsp104 to the nucleus to interact with latent translation initiation factor eIF2 and to suppress protein aggregation. Hindering Hsp104 from entering the nucleus in quiescent cells results in delayed re-entry into the cell cycle due to compromised resumption of protein synthesis. In sum, we report that cytosolic-nuclear partitioning of the Hsp104 disaggregase is a critical mechanism to protect the latent protein synthesis machinery during quiescence in yeast, ensuring the rapid restart of translation once nutrients are replenished.
OriginalsprogEngelsk
Artikelnummer315
TidsskriftNature Communications
Vol/bind15
Udgave nummer1
Antal sider20
ISSN2041-1723
DOI
StatusUdgivet - 2024
Eksternt udgivetJa

Bibliografisk note

Funding Information:
This work was supported by the Austrian Science Fund FWF (J4342-B21 to V.K., J4398-B to A.K.), the Swedish Research Council Vetenskapsrådet (2019-05249 to S.B., 2019-04004 to J.L.H. and 2019-04052 to C.A.), the Deutsche Forschungsgemeinschaft (213249687 and 325871075 to A.I.), the Knut and Alice Wallenberg foundation (2017.009 to T.N., J.L.H., M.O., C.A., and S.B.), Stiftelsen Olle Engkvist Byggmästare (207-0527 to S.B.), and Cancerfonden (211865 to J.L.H., 201045 to C.A., and 222488 to S.B.). pIM701 was a gift from Jiří Hašek (RRID: Addgene_74642). The authors acknowledge support from the Clinical Proteomics Mass Spectrometry at Karolinska University Hospital and Science for Life Laboratory as well as from the Protein Analytics Unit at the Biomedical Center, Ludwig-Maximilians University Munich, for providing assistance in mass spectrometry and data analysis.

Publisher Copyright:
© 2024, The Author(s).

ID: 379650356